Navigating formula shortages: associations of parental perspectives on transitioning to alternative infant formulas for cow's milk protein allergy during the 2022 …
AL Fabbrini, AA Farrar, JM Brown, LV Oliveros… - Frontiers in …, 2024 - frontiersin.org
The COVID-19 pandemic led to supply chain disruptions causing a severe shortage of infant
formula. The shortage impacted parents of infants with cow's milk protein allergy (CMPA) …
formula. The shortage impacted parents of infants with cow's milk protein allergy (CMPA) …
[HTML][HTML] Clinician experience with using hypoallergenic formulas to treat infants with suspected cow's milk protein allergy: a secondary analysis of a prospective survey …
Purpose Cow's milk protein allergy (CMPA) is a common condition in infants, but little is
known about healthcare providers' clinical experience treating infants with CMPA. To …
known about healthcare providers' clinical experience treating infants with CMPA. To …
Impact of the 2022 national formula shortage on clinical decision-making of healthcare providers in switching amino acid formulas for infants with cow's milk protein …
Background In 2022, the United States experienced a national shortage of infant formula
due to a global supply chain crisis and a large-scale domestic formula recall. The existing …
due to a global supply chain crisis and a large-scale domestic formula recall. The existing …
Managing cow's milk protein allergy during the 2022 formula shortage: decision-making among pediatric healthcare providers
LV Oliveros, JM Brown, AL Fabbrini, AA Farrar… - Frontiers in …, 2024 - frontiersin.org
Introduction Cow's milk protein allergy (CMPA) affects 2%-7% of infants and is managed
with hypoallergenic formulas. The 2022 recalls of infant formulas due to factors including …
with hypoallergenic formulas. The 2022 recalls of infant formulas due to factors including …
Extensively Hydrolyzed Formula and Infant Colic Symptoms: Secondary Analysis of a Prospective Cohort Study
Cow's milk protein allergy (CMPA) affects 2% to 3% of infants and is managed with
hypoallergenic formulas. The 2022 recalls of infant formulas due to factors including …
hypoallergenic formulas. The 2022 recalls of infant formulas due to factors including …
[HTML][HTML] Real-Time Data Collection Utilizing Mobile Technology in Clinical Research: A Secondary Analysis of a Prospective Cohort
Introduction: Clinical research faces the challenge of declining physician participation in the
pursuit of advancing evidence-based medicine. This secondary analysis focuses on the …
pursuit of advancing evidence-based medicine. This secondary analysis focuses on the …